Result of the 2020 Annual General Meeting
Zotefoams plc
Result of the 2020 Annual General Meeting
The 2020 Annual General Meeting of Zotefoams plc was held at the offices of Zotefoams plc, 675 Mitcham Road, Croydon CR9 3AL on 8 June 2020.
Proxy votes were received from shareholders in respect of 22,890,906 ordinary shares amounting to 47.1% of the issued share capital. The total number of ordinary shares in issue in relation to the AGM is 48,621,234.
All resolutions put to the meeting were passed on a show of hands. The proxy votes cast in respect of the resolutions received prior to the meeting were as follows:
|
Resolution |
For |
Against |
Discretion |
Votes Withheld |
|
|
1. |
To receive the Annual Report of the Company for the year ended 31 December 2019. |
22,875,128 |
4,078 |
11,699
|
0 |
|
2. |
To approve the New Directors' Remuneration Policy. |
20,542,091 |
2,331,595 |
12,699 |
4,520 |
|
3. |
To approve the Annual Statement by the Chair of the Remuneration Committee and the Annual Report on Remuneration for the year ended 31 December 2019. |
22,866,741
|
9,931 |
12,699
|
1,384 |
|
4. |
To elect A M Fielding as a Director. |
22,879,207
|
0 |
11,699
|
0 |
|
5. |
To elect C.A Wall as a Director . |
22,879,207 |
0 |
11,699 |
0 |
|
6. |
T o re-elect S P Good as a Director. |
21,999,130 |
876,940
|
11,699
|
3,136 |
|
7. |
T o re-elect D B Stirling as a Director. |
22,876,093 |
3,114
|
11,699
|
0 |
|
8. |
T o re-elect G C McGrath as a Director. |
22,876,093
|
3,114
|
11,699
|
0 |
|
9. |
To re-elect D G Robertson as a Director. |
22,876,071
|
0
|
11,699 |
3,136 |
|
10. |
To re-elect J D Carling as a Director. |
22,879,207
|
0
|
11,699
|
0 |
|
11. |
To re-appoint PricewaterhouseCoopers LLP as Auditors of the Company. |
22,758,354
|
853 |
11,699
|
120,000
|
|
12. |
To authorise the Audit Committee to determine the Auditors' remuneration. |
22,878,354
|
853 |
11,699
|
0
|
|
13. |
To authorise the Directors to allot shares. |
22,678,500
|
195,685
|
13,585
|
3,136
|
|
14. |
To authorise the Directors to allot equity securities for cash. |
22,747,057
|
132,150
|
11,699
|
0
|
|
15. |
To authorise the Directors, in addition to resolution 14, to allot further equity securities for financing (and refinancing) purposes only. |
22,742,978
|
136,228
|
11,699
|
0
|
|
16. |
To authorise market purchases of shares. |
22,874,816
|
4,390
|
11,699
|
0
|
|
17. |
That a general meeting other than an annual general meeting may be called on not less than 14 clear days' notice. |
22,588,685
|
290,522
|
11,699
|
0 |
Resolutions 1 to 13 inclusive were passed as ordinary resolutions and resolutions 14 to 17 inclusive were passed as special resolutions.
Further details of the resolutions (including the text of the resolutions) are given in the Notice of the 2020 Annual General Meeting which is at the rear of the 2019 Annual Report and which is also available on the Company's website.
Lydia Harratt
Group Company Secretary
8 June 2020
About Zotefoams plc
Zotefoams plc (LSE - ZTF) is a world leader in cellular materials technology delivering optimal material solutions for the benefit of society. Utilising a variety of unique manufacturing processes, including environmentally friendly nitrogen expansion for lightweight AZOTE® polyolefin and ZOTEK® high-performance foams, Zotefoams sells to diverse markets worldwide. Zotefoams uses its own cellular materials to manufacture T-FIT® advanced insulation for demanding industrial markets. Zotefoams also owns and licenses patented microcellular foam technology to reduce plastic use in extrusion applications and for ReZorce® mono-material recyclable barrier packaging.
Zotefoams is headquartered in Croydon, UK, with additional manufacturing sites in Kentucky and Oklahoma, USA (foam products manufacture and conversion), Massachusetts, USA (MuCell Extrusion) and Jiangsu Province, China (T-FIT®). A third foam-manufacturing site, in Poland, is planned to begin operations in 2020.
AZOTE®, ZOTEK®, ReZorce® and T-FIT® are registered trademarks of Zotefoams plc.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Latest directors dealings
- 1 day ago Savannah Energy
- 1 day ago Buccaneer Energy PLC
- 1 day ago Savannah Energy
- 1 day ago Carclo
- 1 day ago Schroder Japan Growth Fund